Inspiratory muscle training for people with Long COVID
Does a 4-week Inspiratory Muscle Training Intervention (IMT) Increase Inspiratory Muscle Pressure (MIP) and Other Functional Outcomes in People With Long COVID? A Pilot Investigation
This study is testing if a 4-week breathing exercise program can help people with Long COVID improve their lung function and ability to exercise.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 16 (estimated) |
| Ages | 18 Years to 65 Years |
| Sex | All |
| Sponsor | University of Bath Academic / other |
| Locations | 1 site (Bath) |
| Trial ID | NCT06091358 on ClinicalTrials.gov |
What this trial studies
This pilot investigation aims to evaluate the effectiveness of a 4-week individualized inspiratory muscle training intervention for individuals suffering from Long COVID. Participants will undergo baseline and follow-up testing, including spirometry and functional assessments, to measure improvements in respiratory function and exercise capacity. The study will randomly assign participants to either an intervention or control group, with comprehensive testing conducted at the beginning and end of the intervention period.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 65 who have been experiencing breathlessness for more than three months following a COVID-19 infection.
Not a fit: Patients who are pregnant, have a history of cardiac events, dementia, high fall risk, chronic respiratory diseases, or are currently receiving respiratory muscle training or steroid inhaler treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this intervention could significantly improve respiratory function and quality of life for patients with Long COVID experiencing dyspnea.
How similar studies have performed: While this approach is relatively novel, similar interventions targeting respiratory rehabilitation have shown promise in other populations, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Experiencing self reported Dyspnea (Breathlessness) following COVID-19 infection over 3 months ago. * Aged between 18 and 65 Exclusion Criteria: * Are pregnant * Receiving treatment following a previous cardiac event (Myocardial-infarction and Non-ST elevation MI), * Have a dementia diagnosis, * Have a high risk of falls, * Have an additional chronic respiratory disease diagnosis such as (Chronic obstructive pulmonary disease) COPD or CF (cystic fibrosis) * Are receiving respiratory muscle training * Are receiving steroid inhaler treatment
Where this trial is running
Bath
- The University of Bath — Bath, United Kingdom (Recruiting)
Study contacts
- Study coordinator: Rachel Eddy
- Email: re415@bath.ac.uk
- Phone: 00000000
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.